According to the research report titled ‘Global infectious disease test device market Size study with COVID impact, by Product & Service (Assays, Kits, & Reagents, Instruments, Services and Software) by Disease Type (Hepatitis, HIV, CT/NG, HAIs, HPV, TB, Influenza, Other Diseases) by Technology (Immunodiagnostics, Clinical, Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, Other Technologies) by End User (Hospitals/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users) and Regional Forecasts 2020-2027‘, available with Market Study Report, global infectious disease test device market was valued at USD 16.4 billion in 2019 and is expected to grow with a CAGR of 5.60% during 2020-2027.
 

Increasing prevalence of infectious diseases such as HPV, HIV, influenza, hepatitis, and tuberculosis despite notable improvements in sanitation practices is the major factor expected to drive global infectious disease test device market growth during the forecast period.
 

Notably, almost all the presently available standard diagnostic test kits are used for sexually transmitted diseases and bacterial infections. Some of the tests do not have their own HCPCS codes, and instead are charged with the help of unlisted codes, which is a factor expected to restrain the market growth during forecast period. Despite that, increasing consumer awareness regarding the benefits of personalized medicine is creating opportunities for molecular diagnostics and proteomics & genomics technologies, in turn augmenting global infectious disease test device market outlook.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2706213/
 

Based on end user scope, global infectious disease test device industry is segmented into physician offices, hospitals/clinical laboratories, reference laboratories, academic/research institutes, and others. With regards to technology spectrum, the industry is bifurcated into DNA microarrays, INAAT, immunodiagnostics, PCR, clinical microbiology, DNA sequencing & NGS, and others.
 

As per disease type, the industry is segmented into CT/NG, Hepatitis, TB, Influenza, HPV, HAIs, HIV, and others. Speaking of the product & service terrain, global infectious disease test device market is bifurcated into services & software, assays, kits, & reagents, and instruments.
 

From regional frame of reference, North America accounted for 44% share of worldwide infectious disease test device market in 2019 and is expected to showcase modest growth trends during the forecast period, mainly due to rise in awareness among practitioners and patients, favorable government measures, and presence of robust healthcare infrastructure in the region.
 

Meanwhile, Asia Pacific infectious disease test device industry is expected to witness the highest growth rate through 2027, owing to favorable government measures for testing of infectious disease. Further, unmet medical needs, economic development, and significant rise in disposable income, along with surging healthcare expenditure in emerging nations such as China, India, and South Korea are swaying the business dynamics in Asia Pacific.
 

Major players influencing global infectious disease test device market trends include Bio-Rad Laboratories, Becton, Dickinson & Company, Luminex Corporation, Abbott Laboratories, BioMerieux SA, DiaSorin Inc., Siemens AG, Roche Diagnostics AG, Quidel Corporation, Danaher Corporation, Meridian Bioscience Inc., and Thermo Fisher Scientific Inc.